EDAP TMS SA (EDAP)
4.60
+0.04
(+0.88%)
USD |
NASDAQ |
Jun 08, 16:00
EDAP TMS SG&A Expense (Quarterly) : 12.96M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cellectis SA | 5.610M |
| Trinity Biotech Plc | 7.304M |
| DBV Technologies SA | 15.36M |
| Akari Therapeutics Plc | 2.165M |
| Sanofi | -- |